North America Intravascular Ultrasound (IVUS) Systems Market - 2025-2033

The North America intravascular ultrasound (IVUS) systems market size reached US$ 345.15 million in 2024 and is expected to reach US$ 567.64 million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

Intravascular ultrasound (IVUS) is a medical imaging technique used to visualize the inside of blood vessels, particularly coronary arteries, by using ultrasound waves. Unlike traditional imaging methods such as X-ray angiography, which only shows the exterior of blood vessels, IVUS provides high-resolution, cross-sectional images of the vessel walls, the lumen (the inside space), and any plaque or other abnormalities within the arteries. IVUS is used in interventional cardiology for diagnostic and procedural guidance, offering crucial insights during angioplasty, stenting, and other vascular procedures.

Intravascular ultrasound (IVUS) is an advanced, highly effective imaging technique that provides a detailed, real-time view of the inside of blood vessels. It plays a crucial role in diagnosing coronary artery disease, guiding cardiovascular interventions like angioplasty and stent placement, and monitoring plaque vulnerability and stent deployment. By offering detailed images of both the lumen and the arterial walls, IVUS enables better clinical decision-making, more accurate interventions, and improved patient outcomes. Its minimally invasive nature, high resolution, and ability to provide comprehensive vascular assessment make it an essential tool in modern interventional cardiology.

Market Dynamics: Drivers & Restraints

Rising technological advancements are significantly driving the Intravascular ultrasound (IVUS) systems market growth.

Rising technological advancements play a pivotal role in driving the growth of the North America intravascular ultrasound (IVUS) systems market, particularly in the development and adoption of various IVUS devices and catheters. Continuous innovation in imaging technologies is expected to enhance the precision and efficiency of cardiac interventions. Thus, the major market players are focusing on the technological advancements in IVUS devices, which further accelerate the market growth.

For instance, in October 2024, Boston Scientific launched AVVIGO, an AI-powered multimodality guidance system designed to enhance percutaneous coronary intervention (PCI) procedures. The system combines IVUS vessel imaging with fractional flow reserve (FFR) technology, offering high-quality images and advanced physiological data to improve decision-making and precision during coronary interventions.

These advancements enable better stent placement, optimal coronary artery assessment, and reduced risk of complications like stent thrombosis. The continued evolution of IVUS systems, coupled with advancements in software and AI, is set to redefine the standards of care, fueling market growth in North America. These technologically advanced IVUS systems, such as AI-powered IVUS improving vascular imaging and patient outcomes, which booming the market growth.

For instance, in March 2025, Evident Vascular, Inc. successfully closed its Series B financing, securing investment from Shangbay Capital, two undisclosed multinational strategics, and founding investor Vensana Capital. The funding will accelerate the development of its AI-powered IVUS platform, aimed at improving vascular imaging and patient outcomes, and support FDA 510(k) clearance ahead of its U.S. market launch.

The high cost of advanced technologies is hampering market growth

The high cost of advanced technologies is a significant restraint on the growth of the intravascular ultrasound (IVUS) systems market. For instance, an IVUS imaging console and a one-time use disposable IVUS catheter cost $90,000 to $180,000 and ~$1,000, respectively.

These costs of the systems might not be affordable to healthcare practitioners in North America. While these technologies offer improved precision and patient outcomes, their high upfront costs can limit adoption, especially in budget-constrained healthcare environments. Many hospitals and clinics struggle to justify the investment in expensive imaging equipment and software, especially when faced with competing priorities for resources.

Additionally, the ongoing costs associated with maintenance, software updates, and training for medical professionals can further deter adoption. As a result, the high cost of these advanced systems may slow their widespread implementation, limiting access to cutting-edge cardiac care and slowing overall market expansion in certain regions.

Segment Analysis

The North American intravascular ultrasound (IVUS) systems market is segmented based on product type and end-user.

Product Type:

The IVUS catheters from the product type segment are expected to dominate the intravascular ultrasound (IVUS) systems market with the highest market share.

IVUS catheters are miniaturized ultrasound probes integrated into flexible, catheter-based devices that are inserted into blood vessels to provide real-time, high-resolution, cross-sectional imaging of the vessel lumen and walls. These catheters utilize high-frequency sound waves to generate detailed images, helping physicians assess plaque burden, vessel morphology, and stent positioning during interventional cardiology and vascular procedures.

IVUS catheters are a key component of IVUS technology, playing a critical role in the diagnosis and treatment of cardiovascular diseases (CVDs). These miniaturized ultrasound probes provide high-resolution, real-time imaging of blood vessels, enabling cardiologists to assess vessel morphology, plaque composition, and stent positioning with superior accuracy. The growing adoption of image-guided interventions has significantly boosted the demand for IVUS catheters, making them a major driver of market expansion.

Continuous advancements in IVUS catheter technology, making procedures safer, faster, and more efficient. Leading medical device companies such as Boston Scientific, MicroPort Scientific Corporation, and other emerging players, are focusing on next-generation IVUS catheters.

For instance, in March 2024, Boston Scientific Corporation launched its iCross Coronary Imaging Catheter, a product designed to improve the deliverability of the Company's market-leading intravascular ultrasound (IVUS) technology, the iLab Ultrasound Imaging System. IVUS technology enables physicians to see detailed images inside the heart and coronary arteries. The Company said the iCross Catheter would be available immediately in the United States.

IVUS catheters are essential tools, playing a pivotal role in guiding complex interventions, improving patient outcomes, and expanding the market for minimally invasive procedures. Their ability to provide detailed intravascular imaging has not only enhanced procedural safety but has also driven technological advancements and broader clinical adoption. As cardiovascular disease prevalence rises and minimally invasive procedures become the standard of care, the IVUS catheter market will continue to expand, solidifying its position as a critical driver of the IVUS industry.

Furthermore, the partnerships and collaborations between various companies and other organizations are accelerating market growth by developing advanced IVUS catheters. For instance, in July 2022, Intravascular Imaging Incorporated (i3) launched its 3-F NIRF-IVUS near-infrared fluorescence imaging intravascular ultrasound catheter, which was designed in collaboration with Massachusetts General Hospital in Boston, Massachusetts. NIRF-IVUS enables visualization of the molecular and cellular details that underlie the pathophysiologic progression of coronary lesions, arterial dissections, coronary transplant vasculopathy, and fibrin production in unhealed stents.

Competitive Landscape

Top companies in the North America intravascular ultrasound (IVUS) systems market include Boston Scientific Corporation, TERUMO CORPORATION, Koninklijke Philips N.V., Nipro, and ACIST Medical Systems, among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The North America intravascular ultrasound (IVUS) systems market report delivers a detailed analysis with 21 key tables, more than 18 visually impactful figures, and 198 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.